| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/08/2002 | EP1203769A1 Hypolipidemic 1,4-benzothiazepine derivative |
| 05/08/2002 | EP1203767A1 Heterocyclic-substituted alkylamide acat inhibitors |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1203764A1 Benzamidine derivatives with LTB4-antagonistic activity |
| 05/08/2002 | EP1203761A2 Calcium receptor-active compounds |
| 05/08/2002 | EP1203587A1 A medicament and method for the production thereof |
| 05/08/2002 | EP1203586A2 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin. |
| 05/08/2002 | EP1203585A1 Anti-ischemic agent |
| 05/08/2002 | EP1203583A1 Remedies for arthrosis deformans |
| 05/08/2002 | EP1203582A1 Medicinal compositions for treating lower uropathy |
| 05/08/2002 | EP1203581A2 Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
| 05/08/2002 | EP1203580A1 Quickly disintegrating solid preparations |
| 05/08/2002 | EP1203531A2 Water soluble compositions containing chlorhexidine and their use |
| 05/08/2002 | EP1203239A2 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 05/08/2002 | EP1203092A1 Antisense modulation of map kinase kinase 6 expression |
| 05/08/2002 | EP1203088A2 Conditionally controlled, attenuated hiv vaccine |
| 05/08/2002 | EP1203020A1 Modulation of human sodium channels in dorsal root ganglia |
| 05/08/2002 | EP1203018A1 26 human prostate and prostate cancer associated proteins |
| 05/08/2002 | EP1203011A1 Orally active androgens |
| 05/08/2002 | EP1203010A1 Antisense modulation of fadd expression |
| 05/08/2002 | EP1203009A1 Antisense modulation of jun n-terminal kinase kinase-1 expression |
| 05/08/2002 | EP1203008A1 Nucleic acid ligands to cd40ligand |
| 05/08/2002 | EP1203007A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1202999A1 Novel 2-decarboxy-2-phosphinico prostaglandin f analogs |
| 05/08/2002 | EP1202996A1 Titanium derived compounds, preparation and use thereof |
| 05/08/2002 | EP1202994A1 New compounds |
| 05/08/2002 | EP1202993A2 Phenanthroline-7-one derivatives and their therapeutic uses |
| 05/08/2002 | EP1202992A2 Ascididemin derivatives and their therapeutic applications |
| 05/08/2002 | EP1202991A1 Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation |
| 05/08/2002 | EP1202990A2 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
| 05/08/2002 | EP1202989A1 Benzamide derivatives |
| 05/08/2002 | EP1202988A2 Novel integrin receptor antagonists |
| 05/08/2002 | EP1202987A2 Quinoline derivatives and their use as antibacterial agents |
| 05/08/2002 | EP1202986A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 05/08/2002 | EP1202984A1 Novel diphenyl-piperidine derivate |
| 05/08/2002 | EP1202980A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 05/08/2002 | EP1202976A1 Pyrazinones, compositions containing such compounds |
| 05/08/2002 | EP1202975A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 05/08/2002 | EP1202974A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/08/2002 | EP1202971A2 Pharmaceutical compositions comprising 4-quinolones |
| 05/08/2002 | EP1202970A1 Cyclic amine derivatives for the treatment of neurological diseases |
| 05/08/2002 | EP1202969A2 Biphenyl derivatives, production thereof and use as medicines |
| 05/08/2002 | EP1202968A2 Antibacterial agents |
| 05/08/2002 | EP1202967A2 Sulfuric acid mono-[3-((1-(2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl)-hydroxy-methyl)-2-methoxy-phenyl]ester |
| 05/08/2002 | EP1202966A1 Piperidine alcohols |
| 05/08/2002 | EP1202965A1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 05/08/2002 | EP1202964A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 05/08/2002 | EP1202963A1 Spla2 inhibitors |
| 05/08/2002 | EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 05/08/2002 | EP1202959A1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
| 05/08/2002 | EP1202957A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 05/08/2002 | EP1202955A2 1,4-substituted 4,4-diaryl cyclohexanes |
| 05/08/2002 | EP1202954A1 Novel aminobenzophenones |
| 05/08/2002 | EP1202953A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 05/08/2002 | EP1202755A1 Cartilage or bone matrix as a nucleic acid delivery vehicle |
| 05/08/2002 | EP1202749A2 Enzyme catalyzed anti-infective therapeutic agents |
| 05/08/2002 | EP1202748A2 Polycation-based bioconjugates |
| 05/08/2002 | EP1202747A1 Sustained release drug dispersion delivery device |
| 05/08/2002 | EP1202746A1 Nsaid and efgr kinase inhibitor containing composition for the treatment or inhibition of colonic polyps and colorectal cancer |
| 05/08/2002 | EP1202745A1 Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them |
| 05/08/2002 | EP1202739A1 Rapid immediate release oral dosage form |
| 05/08/2002 | EP1202738A1 Dihydropyrazine derivatives as npy antagonists |
| 05/08/2002 | EP1202737A2 Antiviral therapy use of p-glycoprotein modulators |
| 05/08/2002 | EP1202736A1 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 05/08/2002 | EP1202735A2 Method of cancer treatment |
| 05/08/2002 | EP1202734A1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/08/2002 | EP1202733A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/08/2002 | EP1202732A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202731A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202730A2 Use of ep4 receptor ligands in the treatment of neuropathic pain and colon cancer |
| 05/08/2002 | EP1202729A1 Phosphate transport inhibitors |
| 05/08/2002 | EP1202728A2 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins, and their stimulating effects on the immune response |
| 05/08/2002 | EP1202727A1 Use of agonists of gabab receptors and pharmaceutically acceptable derivatives thereof, in the therapy of maintaining nicotine abstinence in nicotine-dependent patients |
| 05/08/2002 | EP1202726A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202725A1 Method of treating symptoms of hormonal variation, including hot flashes |
| 05/08/2002 | EP1202724A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202723A2 Use of anti-muscarinic agents for treating skin disorders |
| 05/08/2002 | EP1202722A1 Uses compositions for treating or preventing sleep disturbances using very low doses of cyclobenzaprine |
| 05/08/2002 | EP1202721A1 Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof |
| 05/08/2002 | EP1202720A1 Use of gaba agonists for treatment of spastic disorders, convulsions, and epilepsy |
| 05/08/2002 | EP1202719A1 Anesthetic composition for intravenous injection comprising propofol |
| 05/08/2002 | EP1202718A2 Substituted guanidines for the treatment of cancer and pain |
| 05/08/2002 | EP1202717A2 Naaladase inhibitors in anxiety and memory disorders |
| 05/08/2002 | EP1202716A1 Rapidly dissolving dosage form and process for making same |
| 05/08/2002 | EP1202715A2 Quick-release extrudates, method for preparing the same and compositions obtained from said extrudates |
| 05/08/2002 | EP1202713A2 Artificial tear replacement solution |
| 05/08/2002 | EP1202700A1 Oil-in-water emulsion with improved stability |
| 05/08/2002 | EP1202639A2 Methods for suppressing appetite and enhancing exercise and recovery |
| 05/08/2002 | EP1202630A1 Natural, anti-bacterial, anti-inflammation, anti-virus, anti-herpes cream |
| 05/08/2002 | EP1202628A1 Novel hypoxanthine and thiohypoxanthine compounds |
| 05/08/2002 | EP1202626A1 Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
| 05/08/2002 | EP1202620A1 Anti-inflammatory therapy for inflammatory mediated infection |
| 05/08/2002 | EP1087966B1 Chemical synthesis of morpholine derivatives |
| 05/08/2002 | EP1024823B1 Prevention and treatment of adhesion formation |
| 05/08/2002 | EP1007040B1 Use of phanquinone for the treatment of alzheimer's disease |
| 05/08/2002 | EP0923585B1 Phosphinate based inhibitors of matrix metalloproteases |
| 05/08/2002 | EP0914332B1 Isoquinolines useful as analgesics |
| 05/08/2002 | EP0888301A4 Mcbi analogs of cc-1065 and the duocarmycins |
| 05/08/2002 | EP0852489B1 Hair care composition including at least one silicone polymer grafted by anionic, amphoteric or non-ionic monomers, and at least one amphoteric polymer |